D. S. Tan

Combined modality management of advanced cervical cancer including novel sensitizers

M. Tseng, Natalie Y L Ngoi, D. S. Tan, 2022, International Journal of Gynecological Cancer.

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.

E. Kohn, V. Gebski, A. Reuss, 2022, The Lancet. Oncology.

A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma

A. Okamoto, T. Tan, C. Herrington, 2021, The Journal of pathology.

OTT_A_309661 3921..3928

Arunachalam, Natalie, D. Lim, 2021 .

Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer.

Y. Soon, R. Huang, B. Goh, 2022, The Cochrane database of systematic reviews.

Abstract CT022: CheckMate 848: A randomized, open-label, phase 2 study of nivolumab in combination with ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden

P. Ascierto, M. Burotto, T. Ciuleanu, 2022, Cancer Research.

First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.

D. Virshup, B. Madan, Jeffrey Hill, 2017 .